TNYA: Tenaya Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 160.03
Enterprise Value ($M) 151.79
Book Value ($M) 112.60
Book Value / Share 1.42
Price / Book 1.42
NCAV ($M) 57.35
NCAV / Share 0.72
Price / NCAV 2.79

Profitability (mra)
Return on Invested Capital (ROIC) -0.92
Return on Assets (ROA) -0.61
Return on Equity (ROE) -0.71

Liquidity (mrq)
Quick Ratio 5.27
Current Ratio 5.27

Balance Sheet (mrq) ($M)
Current Assets 85.33
Assets 140.58
Liabilities 27.98
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2 days ago 13D/A Beehouse, LLC 0.03 -99.83
2 days ago 13G/A Price T Rowe Associates Inc /md/ 3.80 -33.36
2 days ago 13G/A Ra Capital Management, L.p. 9.99 14.86
02-14 13G/A Rtw Investments, Lp 0.00 -100.00
02-14 13D/A Column Group Iii, Lp 17.70 19.60
01-31 13G BlackRock, Inc. 5.60

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 896,807 2,938,831 30.52
2024-11-14 679,951 3,538,957 19.21
2024-11-13 1,177,960 3,896,648 30.23
2024-11-12 1,364,574 5,302,662 25.73
2024-11-11 1,277,220 5,854,684 21.82

(click for more detail)

Similar Companies
TECH – Bio-Techne Corporation TERN – Terns Pharmaceuticals, Inc.
TLRY – Tilray Brands, Inc. TRML – Tourmaline Bio, Inc.
TSHA – Taysha Gene Therapies, Inc.


Financial data and stock pages provided by
Fintel.io